Summary. Sulphonamides with different chemical structures were synthesized and these 13 compounds together with 7 commercially available sulpha drugs were tested for antifertility activity by natural mating in male rats. All compounds were given daily by gastric intubation at doses of 125, 150, 250 or 450 mg/kg for 6 weeks. Sulphapyridine caused a dose-related and reversible reduction in fertility at doses between 125 and 450 mg/kg. At the high dose, fertility was reduced to 25\m=.\9%of control at 5 weeks after treatment, and complete recovery occurred by 3 weeks after drug withdrawal. This activity was abolished when the pyridine ring was substituted by other heterocyclic rings, except sulphachloropyridazine which had only weak activity. Replacement of the pyridine ring by a hydrogen atom or short aliphatic chains preserved or even enhanced the potency. Thus, sulphanilamide, N1-methylsulphanilamide or N1-diethylsulphanilamide produced a marked but reversible reduction in fertility. Removal or substitution of the N4-amino group on the benzene ring of sulphapyridine with a methyl group destroyed the activity. However, the bromo or nitro analogue (at the para-but not the meta-position of the benzene ring) still possessed some activity. N4-Acetyl derivatives of sulphapyridine, sulphanilamide, and N1-diethylsulphanilamide were as potent as their parent compounds. These results suggest that the presence of pyridine or other heterocyclic rings is not necessary for the antifertility activity of sulphonamide compounds. However, the N4-amino group is indispensable. In addition, acetylation of this amino group does not change the potency. The prototype of the antifertility sulphonamides therefore seems to be sulphanilamide.
Introduction
Sulphasalazine (salicylazosulphapyridine), a compound formed by azo linkage between sulpha¬ pyridine and 5-amino salicylic acid, was first introduced to treat rheumatoid arthritis in 1930 (for review see Goldman & Peppercorn, 1975) . It was later demonstrated to be useful in the therapy and prophylaxis of ulcerative colitis and regional enteritis (Baron et ai, 1962; Misiewicz et al., 1965) . Although these diseases predominantly affect men and women of reproductive age, the association between sulphasalazine treatment and male infertility was not recognized until in 1979 when Toth (1979) and Levi et ai (1979) independently reported that male patients who received sulphasalazine treatment for ulcerative colitis became infertile. Such an undesirable effect was completely revers¬ ible after drug withdrawal. This finding has since been confirmed both in man and other animals by many investigators (for review see Giwercman & Skakkebaek, 1986) . More recent evidence indi¬ cates that the sulphapyridine moiety, which is a metabolic breakdown product of sulphasalazine by bacteria in the gut (Peppercorn & Goldman, 1972) , or its metabolite(s), is responsible for the antifertility effect in man (O'Morain et ai, 1982a, b; Cann & Holdsworth, 1984; Mclntyre & Lennard-Jones, 1984; Shaffer et ai, 1984) and in rats (O'Morain et ai, 1982b; Pholpramool & Srikhao, 1985) .
In rats, sulphasalazine and sulphapyridine do not alter testicular weight and histology, gonadotrophin and testosterone concentrations in the blood, or daily sperm production rate and sperm concentration in the epididymis (Pholpramool & Srikhao, 1983; O'Morain et ai, 1984; Pholpramool et ai, 1989) . These, together with the rapid onset of the antifertility activity, suggest that the site of action is post-testicular, possibly at the epididymis. Wong et al. (1987) 
*Generic names are used for the Compounds I VII, which were not synthesized in this study.
Results
The antifertility effect of sulphapyridine Sulphapyridine produced a dose-dependent and reversible reduction in fertility (Table 2) . At a low dose, 125 mg/kg, percentage fertility was significantly (P < 0-001) reduced by 5 weeks after treatment. When given at higher doses, significant reductions occurred by 3 weeks after feeding, and by 5 weeks percentage fertility was only 25% at doses of 250 and 450 mg/kg. In addition, the number of males that mated with female rats and the number of the females that became pregnant were also reduced after feeding with sulphapyridine. These effects, however, were rapidly reversible. Thus, by 1-3 weeks after the cessation of treatment all these parameters returned to control levels ( Table 2) .
Effects of sulphapyridine analogues
To determine the structural requirements for sulphonamide compounds that have antifertility activity and to search for more potent compounds than sulphapyridine, 19 sulphonamides having various structures related to sulphapyridine were chosen for fertility testing in this study.
Compounds with N1 substituted with heterocyclic rings. Figure 1 shows the results of fertility testing of the commercially available sulphonamide drugs that contain several types of heterocyclic rings, other than pyridine, at the A^1 position. It is clear that sulphioxazole, sulphamerazine and sulphadimethoxine failed to exhibit any antifertility activity. However, sulphachloropyridazine, at a dose of 450 mg/kg, caused a slight but significant (P < 005) suppression of fertility. 25-9 ± 8-6ac (6) 77-8 100 69-3 ± 9-6"
88-9 100 901 ± 3-5 Compounds with 1 substituted with aliphatic chains. Table 3 demonstrates the effects of several simple sulphonamides on fertility of male rats. These compounds all had antifertility activity.
Compound VIII (A^-methylsulphanilamide) was the most potent agent, giving a low percentage fertility at 5 weeks after treatment at a dose of 450 mg/kg. The numbers of males that mated and of impregnated females were markedly reduced (Table 3) . At this dose, however, this compound exhibited some toxic effects, i.e. reduction in body weight and haematuria. Nevertheless, these effects were dose-dependent and reversible after the cessation of treatments. 
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(7) (6) (6) (4) (4) (6) 95-5 ± 2-7 60-0 + 24-5 91-9+ 4-8 22-8+ 81cf 47-2+17-1" 550+ 9-2 (8) (Schroder & Campbell, 1972) . However, the active form of sulphapyridine or other antifertility sulphon¬ amides is not known. The effects of A^-acetyl derivatives of sulphapyridine and other antifertility sulphonamides were therefore investigated. The results are shown in Table 5 . All these compounds were also effective in suppressing fertility of the male rats.
Discussion
Since the recognition of the side effects of sulphasalazine on male fertility, it has been demonstrated by several investigators that some sulpha drugs and other related compounds such as sulphapyri- (Wong et ai, 1987) also possess antifertility activities. However, there has been no systematic study on the structure and activity relationship of these compounds. This study is the first attempt to unveil the basic structure that is necessary for the antifertility action of sulphon¬ amides in male rats. Variations of the structure of the test compounds were primarily based on that of sulphapyridine so as to address 3 questions: firstly, is the pyridine ring required for the antifertility activity; secondly, is the presence of the N4-amino group essential for the action; and thirdly, would acetylation of the A^-amino group alter the potency? When the pyridine moiety of sulphapyridine was replaced by isoxazole or pyrimidine ring the antifertility activity was com¬ pletely lost. Thus, sulphioxazole, sulphamerazine and sulphadimethoxine had virtually no effect on fertility (Fig. 1) . However, replacement with the pyridazine ring partly destroyed the activity. For example, sulphachloropyridazine caused a slight but significant reduction in fertility. By contrast, 
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( 2) 72-0 + 11-3d (5) 32-5 + 23-6ad (4) 92-5 + 3-6 (2) 84-2 + 5-9d (8) 68-0 ± I4-3d (7) 51-8 ± 5-8af (6) ± 13-8" (5) ± 15-5d (7) ± (8) ± 13-1 (7) ± 2-9a' (8) Values are mean + s.e.m. for number of rats indicated in parentheses. 'P < 0-05; bP < 0-01; CP < 0-001 when compared to the corresponding periods in the control group. dP < 005;°P < 001; 'P < 0001 when compared to the period before treatment within the same group. when the pyridine ring is substituted by H-or a simple alkyl group the activity was retained or even enhanced. Simple sulphonamides such as sulphanilamide and N'-diethylsulphanilamide (Compound IX) were therefore as effective as sulphapyridine whilst N'-methylsulphanilamide (Compound VIII) was even more potent (Table 3 ). The latter, however, was also toxic to the rats. These results indicate that the pyridine ring at the A'1 position of the sulphonamide skeleton was not essential for the antifertility activity.
It is well known that the presence of the />-amino group in the benzene ring of benzene sulphonamides is essential for the antimicrobial and antibacterial activities of the sulpha drugs (Maren, 1976) . However, it was not known whether this is also true for the activity of these compounds on fertility. Six sulphapyridine analogues which had the A4-amino group removed or replaced by other functional groups were synthesized and tested: removal of the A^-amino group completely abolished the activity (Table 4) . Substitution with a methyl group also failed to retain the activity. However, bromo-or nitro-groups were able to produce some antifertility activity although to a lesser degree than the amino group. The activity was completely lost when the substi¬ tution of a nitro-group was at the meta-or orr/to-position of the benzene ring. These data suggest that the A^-amino group of the benzene sulphonamide compounds is required for maximum antifertility activity. In this regard, it appears that the requirement for an A,4-amino group is similar to that of the antibacterial sulphonamides. However, it does not necessarily imply that the mode of action of these drugs is the same. The findings that Compound XII [4-nitro-/V-2-pyridinylbenzenesulphonamide] and Compound XIV [4-bromo-/V-2-pyridinylbenzenesulphonamide] (Table 4) are also effective may be explained in terms of conversions of these compounds in the animals to active metabolites, possibly through sulphapyridine for Compound XII.
Previous work has shown that detoxification and excretion of sulphapyridine occur through acetylation at the A/4-amino group and hydroxylation at position 5 of the pyridine ring. The hydroxyl group may then be conjugated with glucuronic acid to form glucuronides, which are then excreted by the kidneys (Schroder & Campbell, 1972; Hansson & Sandberg, 1973; Eastwood, 1980) . It is not known at present whether sulphapyridine or its metabolite(s) is the active molecule(s) for the antifertility activity. A series of A^-acetyl derivatives of the sulphonamides that possess antifertility action was synthesized and tested. The potency was virtually unchanged by such modification, except for Compound XVII (A^-acetyl A^-methylsulphanilamide) and Compound XVIII (A'4-acetyl-A'1-diethylsulphanilamide), which were more potent than their non-acetyl analogues at the dose of 450 mg/kg, but only at 1 week and 3 weeks after feeding, respectively (Table 5 ). The results indicated that the^-acetylated derivative may be the active compound. However, it is also possible that the non-acetylated form is in fact the species that exerts the antifertility action. The latter is based on the notion that the A/4-acetylated form may first be hydrolysed by the gut bacteria and the unacetylated form absorbed into the blood. The latter explanation depends on the assumption that all acetylated compounds tested in this study are readily hydrolysable in the gastrointestinal tract. We are currently working to delineate the nature of the active form of the antifertility sulphonamides.
